Announcing Cancer Biomarker Discovery and Assay Development


Tuesday, 13 May 2014

Cineworld: The O2, London, SE10 0DX, UK

Whilst numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers are already being used at some point in patient care.  This event will discuss the further discovery and assay development of genetic, epigenetic, proteomic, glycomic, and imaging biomarkers which can be used for cancer diagnosis, prognosis, and epidemiology.  We provide an informal atmosphere for discussion and debate.  This is an ideal setting for experts to present their work and discuss their findings.

This event  has CPD accreditation and is part off the

Controlling Cancer Summit

The Deadline for abstract submissions for oral presentation is Feb 10th 2014

Abstracts for poster presentation only can be submitted up to two weeks before the event


You can download the instructions for authors at


Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: